Peninsula biotech sheds 20% of jobs to focus on drugs closer to finish line
January 15, 2019 at 17:08 PM EST
The 17-year-old biotech company, a big player in antibody drug research and development, will focus its cash on a maturing pipeline of experimental drugs while letting go of some longtime employees.
